---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: "[[Cholinergic Blocking Drugs for Nonacute Respiratory Symptom Relief]]"
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Lower Respiratory System Drugs]]"
SecondarySubClass: "[[Bronchodilators]]"
BrandName: Incruse Ellipta
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
 Prevention of bronchospasm associated with COPD, chronic bronchitis, and emphysema
62.5 mcg inhalation once daily

### Contraindications
See `= this.DrugClassContra`

### Interactionsde/Adverse Effects
See `= this.DrugClassAdverse`
Stuffy nose, cough, sore throat, muscle-jointâ€“ tooth pain, rapid heartbeat

### Interactions

`= this.ChemLink+this.file.name`

